Ekso Bionics Holdings Inc expected to post a loss of 31 cents a share - Earnings Preview

Chronoscale

26/04/2023 03:02

* Ekso Bionics Holdings Inc  EKSO.OQ   EKSO.O  is expected
to show
a rise in quarterly revenue when it reports  results on April
27. 
    * The San Rafael California California-based  company is
expected
to report  a 9.1% increase in revenue to $2.8 million from $2.57
million a year ago, according to the estimate from one analyst,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Ekso Bionics
Holdings Inc
is for a loss of 31 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "Buy".​
    * Wall Street's median 12-month price target for Ekso
Bionics
Holdings Inc is $9​, above​ its last closing price of $1.56. ​​​

This summary was machine generated April 26 at 02:02 GMT.  All
figures in US dollars  unless otherwise stated